Search

Home > OIS Podcast > Avedro’s Long Wait for FDA Approval is Over
Podcast: OIS Podcast
Episode:

Avedro’s Long Wait for FDA Approval is Over
Category: Business
Duration: 00:12:32
Publish Date: 2016-04-19 23:00:00
Description: The FDA approved Avedro’s New Drug Application for its riboflavin ophthalmic solution/KXL System (corneal cross-linking for the treatment of keratoconus and corneal ectasia following refractive surgery). OIS Co-chair Gil Kliman, an investor in Avedro, lays out the company’s next plans.
Total Play: 0